Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Altura Medical

Request full access

Emerging medical device company developing a next generation endograft technology to treat abdominal aortic aneurysms

San Clemente, United StatesFounded 2008Biotech & Life Sciences

About Altura Medical

Founded in 2008 and based in Menlo Park, California, Altura Medical operated in the medical device sector with a specific focus on treating abdominal aortic aneurysms (AAAs). The company, formerly known as Altura Interventional Inc., developed an endovascular stent graft system designed to offer a less invasive solution for a condition that can be life-threatening if left untreated.

The core of Altura Medical's business was its proprietary stent graft technology. This system featured a distinct bilateral D-stent design, which set it apart by eliminating the need for contralateral limb cannulation, a common step in similar procedures. This simplified the surgical process, potentially reducing procedure times. The device was delivered via an ultra-low-profile 14F system, designed to minimize trauma to the blood vessels during insertion. A key benefit of the system was the ability to reposition the dual aortic endografts during deployment, allowing surgeons to achieve precise placement and maximize the sealing zone just below the renal arteries. Comprised of a braided nitinol endoskeleton and woven polyester graft material, the components were engineered for flexibility and durable sealing.

The company's primary clients were hospitals and vascular surgeons trained in endovascular aneurysm repair (EVAR). In 2015, Altura Medical achieved a significant milestone by obtaining a CE Mark for its endograft system, permitting its sale and use within the European Union. Following this regulatory achievement, Altura Medical was acquired by Lombard Medical in July 2015. The deal was valued at a potential total of over $50 million, consisting of an initial $23 million in stock and assumed liabilities, with up to an additional $27.5 million contingent on regulatory and commercial milestones. At the time of the acquisition, Lombard planned to launch the device in Europe in early 2016 and pursue an Investigational Device Exemption (IDE) from the U.S. FDA to begin clinical trials in the United States.

Source: Dealroom company data

At a glance

Status
Acquired
Open positions
None listed
Dealroom signal
54.4/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jul 2015 $51M $51M Undisclosed —
EARLY VC✓Equity / VC Apr 2013 $6M $24M Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Altura Medical website traffic

Latest recorded traffic for Altura Medical is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Altura Medical in the San Clemente ecosystem

Live from Dealroom

The Altura Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • SV Health Investors
  • New Leaf Venture Partners
  • Advanced Technology Ventures

Other known investors1 additional known investor

  • University of Minnesota Twin Cities
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Clemente HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Altura Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Altura Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.